Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
about
AHNAK2 is a potential prognostic biomarker in patients with PDAC.HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.Breast cancer biomarker measurements and standards.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer.TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.Breast tumour initiating cell fate is regulated by microenvironmental cues from an extracellular matrix.Proteomics analysis of in vitro protein methylation during Src-induced transformation.Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of ChondrocytesDetermination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy.Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy.Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics.Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.The Global Cancer Genomics Consortium's Second Annual Symposium: Genomics Medicine in Cancer Research
P2860
Q33761904-2703056A-D5CE-4977-B526-ABD521EBFC73Q35155602-5CA022E2-C599-4B9D-9988-29724096FCEFQ35678242-2B224C77-7E5E-46F7-906B-13BB85CCB73AQ38076082-78D0138A-A694-4971-813C-21895C2CF507Q38209599-F36E8E82-5034-4C4B-9912-E4B85FD5A9C7Q38262764-85A0E738-0FA7-4A50-AE5A-E8C161B92AEBQ39153926-D0F0185C-86C4-4834-B8B6-39041BF48F55Q39327076-915C4B06-E722-4053-9E4A-5AB342B54064Q39415481-2F477D10-A1C0-499E-AC9B-39CB8DA9D010Q41180083-95C3D0EA-714B-414C-A7C3-0F6B5E89BFBBQ42378682-956136CD-AF06-487C-8D87-9B54C32877F6Q42560600-5569DE20-BC3D-43E1-93B2-06BE315732ECQ51692082-4C7E7DD9-EF39-41CF-942A-9B84137FC8ADQ54291180-B9E35EAD-EE09-4788-9E5A-CC39B64962C9Q54441612-C72DE279-25B9-4C4D-A3BA-C8F73ECDECDCQ54932282-4D5AA791-F279-4C05-AA58-8CA0B4BF2EDE
P2860
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@ast
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@en
type
label
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@ast
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@en
prefLabel
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@ast
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
@en
P2093
Akhilesh Pandey
Genaro Pimienta
Hexin Chen
Jianjun Hu
Marjan Gucek
Min-Sik Kim
Raghothama Chaerkady
Robert N Cole
Saraswati Sukumar
P2860
P304
P356
10.1002/PMIC.201000297
P577
2010-11-01T00:00:00Z